Asco Gi 2024 Agenda. The asco gi 2024 editors’ picks give readers a needed update of the most important information on the topics critical to the practice of gi oncology including diagnostics,. Phase ii results of circulating tumor dna as a predictive biomarker in adjuvant chemotherapy in patients.
Offering new, innovative findings in gi cancer treatment, research, and care, become an exhibitor at the 2024 asco gastrointestinal cancers symposium taking place january. After the 2024 gastrointestinal cancers symposium, jun gong, md, and daneng li, md, sat down to discuss the most relevant trial data to have come from the conference.